Cargando…
miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma
BACKGROUND: Many studies have used miRNA to modulate osteosarcoma development by regulating protein expression, and these studies showed that the expression of EGFR is increased in osteosarcoma. METHODS: Western blot, real-time PCR and immunohistochemical were used to detect the expression of EGFR a...
Autores principales: | Wang, Jiashi, Wang, Guangbin, Li, Bin, Qiu, Chuang, He, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074763/ https://www.ncbi.nlm.nih.gov/pubmed/30104888 http://dx.doi.org/10.2147/OTT.S171304 |
Ejemplares similares
-
miR-141-3p is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma [Retraction]
Publicado: (2023) -
miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2017) -
miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2023) -
miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN
por: He, Ming, et al.
Publicado: (2019) -
Naringin targets Zeb1 to suppress osteosarcoma cell proliferation and metastasis
por: Ming, He, et al.
Publicado: (2018)